▲ 65 r/GettingRidOfHSV+1 crossposts

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program

https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-exercises-us-profit-share-option-gilead-hsv

Based on the article, it can be inferred that Gilead may already have plans for Phase 3

1.This decision follows Assembly Bio’s receipt and review of Gilead’s complete development plan and budget for the program.

2.Under the development plan, GS-1179 is expected to advance into a Phase 2 clinical trial in participants with recurrent genital herpes by the end of 2026, with potential evaluation as part of a combination strategy with HIV pre-exposure prophylaxis (PrEP)

reddit.com
u/FitIndependence9648 — 1 month ago